Paperback. SGLT2 inhibitors, also called gliflozins, are a class of medications that inhibit reabsorption of glucose in the kidney and therefore lower blood sugar. They act by inhibiting sodium-glucose transport protein 2 (SGLT2). SGLT2 inhibitors are used in the treatment of type 2 diabetes mellitus.This book is a concise guide to the use of SGLT2 inhibitors for the treatment of diabetes.Beginning with an overview of the evolution and physiology of SGLT2 inhibitors, the following sections cover the renal, cardiovascular, and metabolic and haemodynamic effects of their use. Adverse effects are also examined.The book concludes with detailed discussion on SGLT2 inhibitor use as a preferred option for management of type 2 diabetes, and currently emerging data for their successful use for treatment of type 1 diabetes.Authored by recognised experts in the field, the book provides clinicians with the latest advances in the field, further enhanced by illustrations and figures to assist learning.Key pointsConcise guide to use of SGLT2 inhibitors for management of diabetesCovers common use for treatment of type 2 diabetes as well as increasing use for type 1 diabetesIn depth discussion on associated systemic effectsHighly illustrated with diagrams and figures Provides detailed information on the novel drug class SGLT-2 inhibitors for the treatment of diabetes. All current evidences, studies and available data have been incorporated. An in depth search of literature on all topics traces how SGLT-2 inhibitors have evolved and are now a preferred option in management of type 2 diabetes. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.

Seller Inventory # 9789352706808

Contact seller

Report this item

Bibliographic Details

Title: Novel Insights on SGLT-2 Inhibitors (Paperback)
Publisher: Jaypee Brothers Medical Publishers, New Delhi
Publication Date: 2020
Language: English
ISBN 10: 9352706803
ISBN 13: 9789352706808
Binding: Paperback
Condition: new

About this title

Synopsis

Provides detailed information on the novel drug class SGLT-2 inhibitors for the treatment of diabetes. All current evidences, studies and available data have been incorporated. An in depth search of literature on all topics traces how SGLT-2 inhibitors have evolved and are now a preferred option in management of type 2 diabetes.

"About this title" may belong to another edition of this title.

Store Description

Visit Seller's Storefront

Seller's business information

APOLLO ONLINE CORP.
605 Geddes Street, Wilmington, DE, 19805, U.S.A.

Sale & Shipping Terms

Terms of Sale

We guarantee the condition of every book as it�s described on the Abebooks web sites. If you�ve changed
your mind about a book that you�ve ordered, please use the Ask bookseller a question link to contact us
and we�ll respond within 2 business days.
Books ship from California and Michigan.

Shipping Terms

Orders usually ship within 2 business days. All books within the US ship free of charge. Delivery is 4-14 business days anywhere in the United States.

Books ship from California and Michigan.

If your book order is heavy or oversized, we may contact you to let you know extra shipping is required.

Shipping rates within U.S.A.

Shipping rates within U.S.A.
Order quantity	6 to 16 business days	6 to 14 business days
First item	US$ 0.00	US$ 0.00

Delivery times are set by sellers and vary by carrier and location. Orders passing through Customs may face delays and buyers are responsible for any associated duties or fees. Sellers may contact you regarding additional charges to cover any increased costs to ship your items.